低剂量阿司匹林治疗患者的双极等离子前列腺剜除术的安全性和有效性。

The Safety and Efficacy of Bipolar Plasma-Kinetic Transurethral Resection of The Prostate in Patients Taking Low-Dose Aspirin.

机构信息

The Department of Urology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.

The Department of Rheumatology and Immunology department, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing,China.

出版信息

Urol J. 2023 Dec 26;20(6):419-423. doi: 10.22037/uj.v20i.7508.

DOI:10.22037/uj.v20i.7508

PMID:37341011

Abstract

PURPOSE

To explore the safety and efficacy of bipolar plasma-kinetic transurethral resection of the prostate in patients taking low-dose aspirin.

MATERIALS AND METHODS

Benign prostatic hyperplasia (BPH) patients who underwent surgical treatment from November 2018 to May 2020 were retrospectively analyzed, and divided into two groups according to whether taking 100mg aspirin daily aspirin or not. The perioperative indexes, complications and sequelae also were used to evaluate safety. The efficacy was evaluated by the functional outcomes in 3,6,12 months.

RESULTS

There were no statistical differences in the baseline characteristics or perioperative indicators and complications and sequelae, except for a longer operative time(90.49 ± 14.34 vs 84.95 ± 15.49; 95%CI: 0.26-10.83; P = .040) and a shorter hospital stay time(HST) (8.52 ± 1.55 vs 9.09 ± 1 .50; 95% CI: 0.21-1.11; P = .042) in the non-aspirin group. During the 12-months follow-up period, the functional outcomes of the two groups were significantly improved except International Index of Erectile Function (IIEF-5).

CONCLUSION

Based on our research results, PKRP a safe and effective method for patients with BPH who taking 100mg aspirin daily.

摘要

目的

探讨在服用低剂量阿司匹林的患者中，双极等离子前列腺切除术的安全性和有效性。

材料与方法

回顾性分析 2018 年 11 月至 2020 年 5 月接受手术治疗的良性前列腺增生（BPH）患者，根据是否每天服用 100mg 阿司匹林分为两组。比较两组围手术期指标、并发症和后遗症，并评价安全性。术后 3、6、12 个月评估疗效。

结果

两组患者的基线特征、围手术期指标及并发症和后遗症差异均无统计学意义，除手术时间较长[（90.49±14.34）s 比（84.95±15.49）s；95%CI：0.26-10.83；P=0.040]和住院时间较短[（8.52±1.55）d 比（9.09±1.50）d；95%CI：0.21-1.11；P=0.042]外。在 12 个月的随访期间，两组患者的功能结局均明显改善，除国际勃起功能指数（IIEF-5）外。